Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Telesis Bio, Inc. - Common Stock (NQ: TBIO ) 3.230 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Telesis Bio, Inc. - Common Stock < Previous 1 2 Next > Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis September 25, 2024 Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities From Telesis Bio Via GlobeNewswire Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market September 10, 2024 From Telesis Bio Via GlobeNewswire Telesis Bio Reports Second Quarter and First Half 2024 Financial Results August 07, 2024 From Telesis Bio Via GlobeNewswire Telesis Bio Reports First Quarter 2024 Financial Results May 09, 2024 From Telesis Bio Via GlobeNewswire Telesis Bio Announces Reverse Stock Split May 06, 2024 From Telesis Bio Via GlobeNewswire Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership April 18, 2024 From Telesis Bio Via GlobeNewswire Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results March 28, 2024 From Telesis Bio Via GlobeNewswire Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA February 26, 2024 Via AB Newswire Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results February 26, 2024 Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expense From Telesis Bio Via GlobeNewswire Telesis Bio Reports Third Quarter 2023 Financial Results November 13, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023 November 07, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA November 03, 2023 New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days From Telesis Bio Via GlobeNewswire Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS September 28, 2023 New Kit expands suite of NGS Library Prep solutions on the BioXp® System Enabling Speed and Efficiency for Whole genome sequencing (WGS) applications with the Automated Molecular Biology Workstation From Telesis Bio Via GlobeNewswire Telesis Bio Appoints William J. Kullback Chief Financial Officer August 29, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio Reports Second Quarter 2023 Financial Results August 10, 2023 -- Total revenue of $8.7M in 2QFY23 - increased by 53% year over year From Telesis Bio Via GlobeNewswire Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023 August 03, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio to Present at Jefferies Healthcare Conference 2023 June 08, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023 June 06, 2023 Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery From Telesis Bio Via GlobeNewswire Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock June 05, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio Secures Financing of $28.0 Million May 31, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio to Present at SynBioBeta 2023 May 23, 2023 Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery From Telesis Bio Via GlobeNewswire Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit May 22, 2023 New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation From Telesis Bio Via GlobeNewswire Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit May 18, 2023 New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation From Telesis Bio Via GlobeNewswire Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023) May 15, 2023 Showcasing Automated Molecular Biology Workstation for Synthetic Biology and Genomics Applications From Telesis Bio Via GlobeNewswire Telesis Bio Reports First Quarter 2023 Financial Results May 11, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023 April 27, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up March 31, 2023 New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation From Telesis Bio Via GlobeNewswire Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance March 21, 2023 From Telesis Bio Via GlobeNewswire Telesis Bio to Present at Festival of Biologics Conference March 16, 2023 Daniel Gibson, Ph.D., CTO and Co-founder to Present “Building Biology Overnight: Eliminating Synthesis Bottlenecks with Hands-free Automated Synthetic Biology Solutions” From Telesis Bio Via GlobeNewswire Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023 March 09, 2023 From Telesis Bio Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.